Trials / Completed
CompletedNCT04512443
Clinical Efficacy of Conservative Treatment in Female Patients With Plevic Congestion Syndrome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 83 (actual)
- Sponsor
- Interregional Clinical Diagnostic Center, Russia · Academic / Other
- Sex
- Female
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The article presents the results of a randomized, placebo-controlled study of the conservative treatment with Daflon (Detralex) in female patients with Pelvic congestion syndrome .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Daflon | All consecutive patients were randomly allocated into 2 groups to receive Daflon (Detralex) at a dose of 1000 mg once daily (study group) or placebo (control group). |
Timeline
- Start date
- 2019-12-28
- Primary completion
- 2020-03-28
- Completion
- 2020-03-28
- First posted
- 2020-08-13
- Last updated
- 2020-08-13
Locations
2 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT04512443. Inclusion in this directory is not an endorsement.